JIN Aoming, PAN Yuesong. Research Progress of Antiplatelet Drugs for Secondary Prevention of Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2023, 18(06): 628-632.
[1]王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中文版)(1)[J]. 中国卒中杂志,2020,15(10):1037-1043.
[2]张倩,贾建平. 缺血性脑血管病的抗血小板治疗进展[J]. 中国临床医生,2014,42(1):15-20.
[3]WALLENTIN L,JAMES S,STOREY R F,et al. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes:a genetic substudy of the PLATO trial[J]. Lancet,2010,376(9749):1320-1328.
[4]CAST(Chinese Acute Stroke Trial)Collaborative Group. CAST:randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke[J]. Lancet,1997,349(9066):1641-1649.
[5]International Stroke Trial Collaborative Group. The international stroke trial(IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19 435 patients with acute ischaemic stroke [J]. Lancet,1997,349(9065):1569-1581.
[6]CAPRIE Steering Committee. A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events(CAPRIE)[J]. Lancet,1996,348(9065):1329-1339.
[7]SHINOHARA Y,KATAYAMA Y,UCHIYAMA S,et al. Cilostazol for prevention of secondary stroke(CSPS 2):an aspirin-controlled,double-blind,randomised non-inferiority trial[J]. Lancet Neurol,2010,9(10):959-968.
[8]王安心,胥芹,夏雪,等. 探索发现道路,创造成就时机——基因指导下的双抗新策略[J]. 中国卒中杂志,2022,17(8):797-801.
[9]DIENER H C,BOGOUSSLAVSKY J,BRASS L M,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients(MATCH):randomised,double-blind,placebo-controlled trial[J]. Lancet,2004,364(9431):331-337.
[10]SACCO R L,DIENER H C,YUSUF S,et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke[J]. N Engl J Med,2008,359(12):1238-1251.
[11]SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke:the SPS3 randomised trial[J]. Lancet,2013,382(9891):507-515.
[12]WANG Y J,WANG Y L,ZHAO X Q,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.
[13]JOHNSTON S C,EASTON J D,FARRANT M,et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA[J]. N Engl J Med,2018,379(3):215-225.
[14]KAUSHIK A,DEORA S,CHOUDHARY R. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA[J]. N Engl J Med,2020,383(17):1692-1693.
[15]WANG Y J,MENG X,WANG A X,et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med,2021,385(27):2520-2530.
[16]BATH P M,WOODHOUSE L J,APPLETON J P,et al. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack:the TARDIS RCT[J]. Health Technol Assess,2018,22(48):1-76.
[17]PAN Y S,MENG X,YUAN B S,et al. Indobufen versus aspirin in patients with acute ischaemic stroke in China(INSURE):a randomised,double-blind,double-dummy,active control,non-inferiority trial[J]. Lancet Neurol,2023,22(6):485-493.